Neolife SAS (8JB) Financial Statements
Neolife SAS Financial Overview
Neolife SAS's market cap is currently $5.61M. The company's EPS TTM is $-0.00; its P/E ratio is -48.50; Neolife SAS has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 12.44M | $ 12.17M | $ 13.43M | $ 13.32M | $ 10.72M |
| Gross Profit | $ 4.15M | $ 349.00K | $ 2.31M | $ -965.69K | $ -360.59K |
| Operating Income | $ -849.00K | $ 464.00K | $ -528.95K | $ -1.03M | $ 8.70K |
| EBITDA | $ -170.00K | $ 1.07M | $ 133.44K | $ -3.04M | $ 616.62K |
| Net Income | $ -117.00K | $ 473.00K | $ -523.53K | $ -3.62M | $ -304.05K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.32M | $ 1.87M | $ 1.05M | $ 1.36M | $ 1.83M |
| Total Assets | $ 9.53M | $ 8.85M | $ 7.35M | $ 8.34M | $ 8.36M |
| Total Debt | $ 749.26K | $ 911.05K | $ 1.47M | $ 2.02M | $ 2.70M |
| Net Debt | $ -294.13K | $ -822.58K | $ 552.57K | $ 657.66K | $ 871.80K |
| Total Liabilities | $ 5.01M | $ 3.91M | $ 3.04M | $ 3.52M | $ 4.28M |
| Stockholders' Equity | $ 4.52M | $ 4.94M | $ 4.30M | $ 4.82M | $ 2.23M |
| Cash Flow | |||||
| Free Cash Flow | $ 612.00K | $ 1.88K | $ 653.00 | $ -1.22M | $ -939.21K |
| Operating Cash Flow | $ 612.00K | $ 1.88K | $ 653.00 | $ -860.84K | $ -94.41K |
| Investing Cash Flow | $ -704.00K | $ -665.00 | $ -421.00 | $ -235.29K | $ -840.88K |
| Financing Cash Flow | $ -324.00K | $ -272.00 | $ -674.00 | $ 624.56K | $ -567.26K |
Currency in EUR
